The study authors tested the risk-reducing effects of ocrelizumab compared with interferon β-1a for treatment of multiple sclerosis disability accumulation, with ocrelizumab showing better results in ...
BALTIMORE -- One in five people in the United States struggle with learning or attention disabilities, according to the Learning Disability Association of America. While they can make learning ...
Homer's odyssey: multiple disability and The best years of our lives / Susan M. Schweik -- Defect: a selective re-interpretation of American immigration history / Douglas C. Baynton -- The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results